Pharma Journalist 9038 posts 0 comments

SMi Reports: Leading microbiologists and industry experts to meet at SMi 10th Anniversary Pharmaceutical Microbiology conference taking place in London in January 2020. SMi Group…
Read More...

GlaxoSmithKline plc (GSK) announced the US Food and Drug Administration (FDA) has approved Nucala (mepolizumab) for the treatment of adult and paediatric patients aged 12 years and…
Read More...

Gilead Sciences, Inc. and Eisai Co., Ltd. announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted Gilead K.K. (Tokyo, Japan) regulatory approval of…
Read More...

AbCellera and IGM Biosciences, Inc. announced that they have entered into a multi-year, multi-target strategic research collaboration and license agreement to facilitate the discovery…
Read More...

Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases, and the US Army Medical Research and Development Command (USAMRDC),…
Read More...

Millendo Therapeutics, Inc. a clinical-stage biopharmaceutical company primarily focused on developing novel treatments for endocrine diseases with significant unmet needs, announced…
Read More...

The Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund, and ChemRar Group have agreed to supply Avifavir, the world's first registered favipiravir-based drug against…
Read More...

Samsung Biologics and Kanaph Therapeutics have entered into a strategic partnership to develop KNP-301, a bi-specific Fc fusion protein intended to treat retinal diseases. According…
Read More...

Novartis Gene Therapies recently received feedback from the US Food and Drug Administration (FDA) following their review of data from the STRONG study of the intrathecal (IT)…
Read More...

Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review to the Company’s supplemental New Drug Application(sNDA)for XALKORI…
Read More...